Sandbox carlos

• Cystoisospora belli Return to Top

• 1. Cystoisospora belli treatment

• 2. Cystoisospora belli prophylaxis

• 2.1 Primary prophylaxis

• 2.2 Secondary prophylaxis (preventing recurrence in patients with CD4 count < 200 cells/mm³)

• Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO 3 times weekly
• Alternative regimen (1): Trimethoprim-sulfamethoxazole 160 mg/800 mg PO qd
• Alternative regimen (2): Trimethoprim-sulfamethoxazole 320 mg/1600 mg PO 3 times weekly
• Alternative regimen (3): Pyrimethamine 25 mg PO qd AND Leucovorin 5–10 mg PO qd
• Alternative regimen (4): Ciprofloxacin 500 mg PO 3 times weekly
• Note (1): Criteria for discontinuation of chronic maintenance therapy: sustained increase in CD4 count > 200 cells/mm³ for > 6 months in response to ART and without evidence of active Cystoisospora belli infection
• Note (2): Because of concerns about possible teratogenicity associated with first-trimester drug exposure, clinicians may withhold secondary prophylaxis during the first trimester and treat only symptomatic infection.

---

• Immunocompetent

• Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO OR IV qid for 10 days

• 1. Patients with sulfa intolerance

• Alternative regimen (1): Pyrimethamine 50-75 mg PO daily AND Leucovorin 10–25 mg PO daily
• Alternative regimen (2): Ciprofloxacin 500 mg PO BID for 7 days

• HIV

• 1. Patients with CD4 Count <200/mm3 (chronic treatment)

• Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO 3 times weekly
• Alternative regimen (1): Trimethoprim-sulfamethoxazole 320 mg/1600 mg PO 3 times weekly
• Alternative regimen (2): Pyrimethamine 25 mg PO daily AND Leucovorin 5–10 mg PO daily
• Alternative regimen (3): Ciprofloxacin 500 mg PO 3 times weekly